Tandem Z-Selective Cross-Metathesis/Dihydroxylation: Synthesis of anti-1,2-Diols
Abstract
A stereoselective synthesis of anti-1,2-diols has been developed using a multitasking Ru catalyst in an assisted tandem catalysis protocol. A cyclometalated Ru complex catalyzes first a Z-selective cross-metathesis of two terminal olefins, followed by a stereospecific dihydroxylation. Both steps are catalyzed by Ru, as the Ru complex is converted to a dihydroxylation catalyst upon addition of NaIO_4. A variety of olefins were transformed into valuable, highly functionalized, and stereodefined molecules. Mechanistic experiments were performed to probe the nature of the oxidation step and catalyst inhibition pathways. These experiments point the way to more broadly applicable tandem catalytic transformations.
Additional Information
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. Received: February 16, 2015; Revised: March 23, 2015. Article first published online: 27 Apr. 2015. This work was financially supported by the ONR (N000141410650), the NIH (5R01M031332-27), and the NSF (CHE-1212767). L. M. Henling is thanked for X-ray crystallography. NMR spectra were obtained using instruments supported by the NIH (RR027690). We thank Dr. J. Hartung for helpful discussions. Materia, Inc. is thanked for the donation of metathesis catalysts.Attached Files
Accepted Version - nihms711195.pdf
Supplemental Material - anie_201501505_sm_miscellaneous_information.pdf
Files
anie_201501505_sm_miscellaneous_information.pdf
Additional details
Additional titles
- Alternative title
- Tandem Z-selective cross metathesis – dihydroxylation for the synthesis of anti-1,2-diols
Identifiers
- PMCID
- PMC4547607
- Eprint ID
- 57186
- Resolver ID
- CaltechAUTHORS:20150504-101350230
Funding
- Office of Naval Research (ONR)
- N000141410650
- NIH
- 5R01M031332-27
- NSF
- CHE-1212767
- NIH
- RR027690
Dates
- Created
-
2015-05-04Created from EPrint's datestamp field
- Updated
-
2022-06-06Created from EPrint's last_modified field